What question did this study set out to answer?

This research aims to evaluate the introduction and rollout of the HPV vaccine in Pakistan, focusing on community response and implementation issues.

June 19, 2026VaccinesOpen Access

Pakistan’s 2025 HPV Vaccine Phase I Rollout: Community Response, Implementation Challenges & Way Forward

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial assesses HPV vaccine coverage and community acceptance in Pakistan, highlighting key challenges and future strategies.

This research aims to evaluate the introduction and rollout of the HPV vaccine in Pakistan, focusing on community response and implementation issues.
Mixed qualitative and quantitative approach to review HPV vaccine rollout.
Participant observation assessed planning, approval, and implementation; quantitative data assessed vaccination coverage and adverse events.
National and regional vaccination coverage statistics evaluated.
Administrative HPV campaign coverage was 75%, with Punjab achieving the highest at 81%.
Community acceptance revealed 71% refusal, primarily due to unavailability during the campaign.
Initial phase coverage (70.6%) exceeded worldwide average of 61.6%, indicating positive progress in a resource-limited context.

Xia et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark